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Abstract
Background: Patients withType II diabetes mellitus are showed to affect the 
sensory, reflex and motor systems in distal extremities. Studies have examined 
the mechanosensitivity and vibration threshold (VT) in type II diabetes mellitus 
patients in the lower limb and compared it with normal individuals. There is 
scanty literature available in comparison of the VTin the upper limb in type II 
diabetes mellitus patients with non-diabetic individuals.
Methods: Thirty type II diabetic individuals (age - 55.60 ± 9.79 years)and 
30 asymptomatic individuals (age - 53.43±9.96) without diabetes mellitus 
participated in the study. Tester at the baseline for both the groups using a 
bioesthesiometer measured VT. Bioesthesiometer is capable of deriving 
a vibration of 100 Hz. Following VTevaluation at the baseline, the tester 
performed the ULNT1 for all the subjects. During the sequence of the ULNT1, 
VTwas measured at initial onset of pain (termed as P1) and short of maximum 
pain (P2) as experienced by the patient.
Results:There was a statistical significant difference inVTbetween diabetic 
and non-diabetic group subjects. VTwas raised in the diabetic group at all the 
three levelsof evaluation (baseline, P1 and P2) compared to the non-diabetic 
group with a p value < 0.001.
Conclusion: VT of the upper limb is higher in individuals with type II diabetes 
mellitus as compared to non-diabetic individuals. 





Diabetes mellitus is a group of metabolic syndrome which is characterized 
by increased levels of glucose in the blood resulting from impaired insulin 
secretion, insulin action, or both [1]. Type II diabetes mellitus is most common 
form which is a disease of insulin resistance that usually has relative (rather 
than absolute) insulin deficiency [1]. Earliest functional change in diabetic 
nerve is change in axonal excitability due to alterations in ion conductance 
of axon membrane due to metabolic processes directly affecting the 
nerves, microvascular abnormalities of the endoneurium and autoimmune 
inflammation [2]. Four main mechanisms have been postulated to underlie 
the pathogenesis of nerve pathology in diabetes mellitus, which are metabolic 
processes directly affecting nerve fibres, endoneurial microvascular disease, 
autoimmune inflammation and deranged neurotrophic support [2,3]. These 
changes are due to these effects of elevated levels of glucose which involves the 
peripheral nerve in type II diabetes mellitus subjects. It has been documented 
that most of type II diabetic patients have peripheral neuropathy [4]. Among 
the nerves, there is a tendency of the large diameter nerve fibers that mediate 
sense of vibration to get involved first in diabetes mellitus [5].
Neurodynamic tests involve sequential limb movements that are 
employed to elicit the connection between physiological and mechanical types 
of different mechanisms [6, 7]. The main ambition of using these different 
tests in assessment of a nerve function is to mechanically stimulate and 
mobilize neural tissues in order to get an expression of their mobility and 
sensitivity to mechanical stresses so as to arouse the physiological responses 
[7, 8]. In order to assess the upper limb nerve function, the standard upper 
limb neurodynamic test 1 (ULNT1) is usually used as it evokes symptoms of 
distribution of the median nerve because the forces generated by this test are 
biased towards this structure [8]. There are various techniques of assessing the 
conductivity of nerve such as nerve conduction velocity that basically assesses 
the motor and sensory aspects of the nerve. Whereas, vibration threshold (VT) 
reflects particular function of the peripheral nervous system especially the 
somatosensory pathway [8,9].
Type II diabetes mellitus patients are showed to affect the different 
multimodal systems (sensory, reflex and motor) in distal extremities [10, 11]. 
Mechanosensitivity in diabetes mellitus patients should be considered as an 
essential inclusion in the assessment to predict the extent of involvement of 
the nerve [11]. Studies have also been done to determine the VTin lower limb 
in normal individuals but there is scanty literature available in comparison of 
the VTin the upper limb in type II diabetes mellitus patients when compared 
with non diabetic subjects.
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Pre-test post-test 2-group cross sectional study design was conductedin 
department of Physical therapy, King Khalid University, Abha, Saudi Arabia.
2.2 Subject Selection
Thirty subjects with type II diabetes with age of 55.60 (SD± 9.79)were 
recruited from the outpatient university physiotherapy clinic who were 
referred from registered practitioner. All subjectswere evaluated by 
experienced physical therapist in the field of diabetes and musculoskeletal 
examination, and the subjects who met inclusion criteria were enrolled into 
the study. Diabetic subjects with clinical signs of neuropathywere excluded 
from the study. Recruitment of age matched normal subjects was done through 
advertisement in the King Khalid University for voluntary participation in the 
study. The subjects were included if are aged between 30 to 70 years, have 
had no H/odiabetes,  upper limb disorders, Cervico-brachial pain syndrome, 
acute inflammatory/ demyelinating diseases, any recent surgeries in upper 
limb. 30control subjects were recruited by age to ensure a similar match to 
the diabetic group. The mean age of the subjects was 53.43±9.96. All the 
subjectswerefamiliarized with the study equipment and testing procedure 
in the first session prior to the actual testing session. All the subjects read, 
understood and signed an informed consent prior to the commencement of the 
study and University ethical committee approved the study. 
3. MEASUREMENT OF VIBRATION THRESHOLD (VT)
VT was measured by the same tester at the baseline for both the groups using 
a bioesthesiometer capable of delivering a vibration of 100 Hz. The subjects 
were made to sit comfortably on a chair with hand and arm placed completely 
on the pillow. The probe of the Vibrometer was placed at the pulp of the distal 
phalanx of the thumb [12]. Either right or left hand was tested. The subjects 
were shielded from the Vibrometer display during testing to avoid any bias. 
At baseline, tester 1 first increased the vibration to a point where the subject 
perceived the stimulus. This was taken as appearance of vibration. Then the 
intensity was further increased and slowly reduced until they identified the 
disappearance of the stimulus. This measurement was done thrice and the 
average of the six values was taken as the vibration threshold.
After the VT was taken at the baseline, the tester performed the ULNT1 
(adopted from M. Shacklock [8] for each individual. For this, a pressure 
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biofeedback inflated to 50 mm Hg was used to prevent shoulder elevation. Then 
the shoulder was abducted to 90-110 degrees followed by complete external 
rotation, forearm supination, wrist and finger extension. The last component of 
ULNT1 was elbow extension and elbow extension value was recorded using 
universal goniometer as a measure of mechanosensitivity. During the sequence 
of the ULNT1, the occurrence of the first response of elbow extension i.e. pain 
considered as P1 was noted. The angle of its occurrence was measured with 
the universal Goniometer and VT at this position in the same manner as that of 
baseline was taken for both the groups by the tester 2. The next occurrence of 
the symptom i.e. P2 at which any further movement was intolerable was noted. 
The corresponding elbow extension angle of P2 was measured. The range of 
elbow extension was reduced until the feeling of discomfort disappeared and 
VT was measured at this point for both the groups by the tester 2. The reduction 
of elbow extension was adopted to avoid the masking of pain for perception of 
vibration. The measurement of VTwas measured for both diabetic individuals 
and age matched normal individuals.
4. DATA ANALYSIS AND RESULTS:
SPSS 20.0 version for windows software was used to analyse the data. 
To be considered statistically significant the p value was set at ≤0.005. 
Demographic data regarding the age (yrs.), sex and duration of individuals 
with type II diabetes mellitus and non-diabetic individuals aresummarizedin 
table no. 1
Table no. 2 and Figure 1 shows the comparison of the VT between the 
diabetic and the non-diabetic group at three levels i.e. VT at baseline, VT at 
P1 and VT at short of P2. There was a statistical significant difference between 
the VT of diabetic and non-diabetic group at the three levels with a p value < 
0.001. This states that the VT was found to be raised in the diabetic group at 
all the three levels compared to the non-diabetic group. Thus, VT of the upper 
limb is higher in individuals with type II diabetes mellitus as compared to non-
diabetic individuals. 
Table 1: Study population characteristics[n = 60] (Mean ± SD).
Diabetic group n= 30 Control group n= 30
Age (yrs) 55.60 ± 9.79 53.43 ± 9.96
Sex Male: female 19:11 15:15
Duration of diabetes 
(yrs.) median (IQR)
5.50 ( 1.75 – 10.50) -
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Our study aimed at comparing the VTof the upper limb during ULNT1 in 
individuals with type II diabetes mellitus and non-diabetic individuals. As per 
the results, the VTwas found to be increased in the individuals with type II 
diabetes mellitus as compared to the non-diabetic individuals. 
VTis a measure of conductivity i.e. a function of the axon in conducting 
the impulse from the external receptor [13]. Thus, alteration of the VTin 
type II diabetic individuals may be due various reasons. Recent studies show 
endoneural hypoxia and reduced neural perfusionare reduced in human 
Table 2: Comparison of Vibration threshold between and within groups.





VT baseline 6.06 ± 1.98 3.72 ± 1.08
Between groups:
p < 0.001
VT at P1 6.24 ± 2.16 4.04 ± 1.24
VT at less than P2 6.46 ± 2.13 3.99 ± 1.40
p value Within groups 0.755
Figure 1: Trend line showing Vibration Threshold difference between 
groups and within group.
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and animal models with diabetes. Investigations on subjects with diabetic 
neuropathy showed structural changes in nerve microvasculature such as 
basement membrane thickening, endothelial cell hyperplasia and pericyte 
degeneration etc.14-16. Reduced endoneural perfusion is also contributed by 
arterio-venous shunting. These changes strongly correlate between nerve 
pathology and vascular changes. Vasa nervorum changes that occur early 
are caused by diabetes mellitus insult, because of such the balance between 
vasodilator and vasoconstrictor are altered [14]. All the above said findings 
might have contributed for increase in VT findings in diabetic group subjects 
when compared to non-diabetic subjects.
The findings of our study regarding the VTare in contrast with the study 
done by David A Gebler et al [17]. They conducted a study to check the 
vibratory and thermal thresholds in normal and diabetic individuals using 
aThermal Sensitivity Tester andOptacon Tactile Tester (OTT). They did not 
find the vibratory and thermal threshold of diabetic subjects to be different 
from the asymptomatic / normal individuals. Our study findings cannot be 
compared with these study findings, as the methodological considerations 
are different from our study. A Gebler et al  [17] study showed that the 
thermal and vibratory thresholds were found to be increasedin diabetic 
individuals with neuropathy [17] but our study did not include subjects with 
neuropathy. Further studies are required to see if there will be differences 
in VT in subjects with diabetic neuropathy and non-neuropathic subjects. 
The limitations of our study include that the study sample was not calculated 
and the sample of 30 is less to compare between diabetics and non-diabetics. 
CONCLUSION
We conclude that VTin subjects with type 2 diabetes mellitus is increased 
when compared to asymptomatic individuals. Physical therapists should 
consider this finding during evaluation and management of patients with type 
ll diabetes mellitus.
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